Ending Hepatitis Before 2030: Challenges and Ways Forward


On the occasion of World Hepatitis Day 2023, this "World We Want" podcast episode focuses on the public health threat of hepatitis and the urgent need to address it to achieve SDG3: Good Health and Well-Being. Here, Márcia Balisciano speaks to Rob Brierley, Editor-in-Chief of The Lancet Gastroenterology & Hepatology to understand the ongoing challenges to achieving this goal, including medical, infrastructural, financial, and other roadblocks.

Rob Brierley

Rob Brierley is Editor-in-Chief of The Lancet Gastroenterology & Hepatology. Rob studied molecular and cellular biochemistry and clinical pharmacology at the University of Oxford, and clinical oncology at the University of Birmingham. Rob has worked in the publishing industry since graduation, first as a technical editor for the Journal of Molecular Biology, before working on a series of viral hepatitis textbooks for a book publisher. Rob joined The Lancet Group in 2004, first at The Lancet Infectious Diseases and The Lancet, before joining The Lancet Oncology as Senior Editor in 2008 and then Deputy Editor in 2012. The Lancet Gastroenterology & Hepatology launched in 2016. Rob’s interests include gastrointestinal and hepatobiliary cancers, viral hepatitis, and inflammatory bowel diseases.